IP Library Patent Application 11466710
Patent Application
App. No. 11/466,710

RAPID METHOD FOR DETECTING MUTATED GENES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/466,710
Abstract

The present invention is a rapid, specific, and sensitive method of detecting mutations in receptor tyrosine kinase genes in formalin fixed tissue embedded in paraffin blocks to detect mutations.

Claims (14)

1 . A method for detecting mutations in the EGFR gene comprising:

removing tissue suspected of having cancer that includes mutations in the EGFR gene from a mammal;

preserving said tissue in formalin fixed paraffin embedded blocks;

fixing thin sections of said preserved tissue on to microscope slides;

introducing antibodies to specific residues to said fixed thin sections of said preserved tissue;

staining said fixed thin section of d) above with a fluorescent or colorimetric-based reagent to detect the presence of said antibodies that have reacted with said specific residues;

imaging said slides to determine the average optical density of the stained tissue; and

calculating the amount of tissue stained and comparing it to a control.

2 . A method according to claim 1 , wherein said antibodies are antibodies to the Y992 and Y1068 phosphorylated tyrosine residues of EGFR.

3 . A method according to claim 2 , wherein the additional steps are performed upon a positive result, comprising:

introducing antibodies to the Y845 phosphorylated tyrosine residues of EGFR to a new fixed thin sections of said preserved tissue;

staining said fixed thin section of h) above with a fluorescent or colorimetric-based reagent to detect the presence of said antibodies to the Y845 phosphorylated tyrosine residue of EGFR;

imaging said slides to determine the average optical density of said stained antibodies; and

determining by calculation the amount of tissue stained and comparing it to a control.

Assignments (3)
SECOND LIEN PATENT SECURITY AGREEMENT Recorded Apr 21, 2009
From: QUINTILES TRANSNATIONAL CORP.; EIDETICS, INC.; QUINTILES, INC.; TARGETED MOLECULAR DIAGNOSTICS, LLC
To: CITICORP NORTH AMERICA, INC., AS COLLATERAL AGENT
Reel/Frame 022570/0319 →
FIRST LIEN PATENT SECURITY AGREEMENT Recorded Apr 20, 2009
From: QUINTILES TRANSNATIONAL CORP.; EIDETICS, INC.; QUINTILES, INC.; TARGETED MOLECULAR DIAGNOSTICS, LLC
To: CITICORP NORTH AMERICA, INC., AS COLLATERAL AGENT
Reel/Frame 022568/0563 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 27, 2006
From: BACUS, SARAH
To: TARGETED MOLECULAR DIAGNOSTICS, LLC.
Reel/Frame 018457/0141 →